A simple innovation the size of a grain of sand means we can now analyse cells and tiny particles as if they were inside the human body.
The new micro-device for fluid analysis will enable more tailored experiments in drug development and disease research.
It could also transform water contamination testing and medical diagnosis in natural disaster zones, where its low cost, simple use and portability make it a practical tool almost anyone can use.
How it works
Microfluidic or ‘lab-on-a-chip’ devices are commonly used to analyse blood and other fluid samples, which are pumped through narrow channels in a transparent chip the size of a postage stamp.
These miniaturised chips are made using state-of-the-art device fabrication facilities at RMIT’s Micro Nano Research Facility.
This new chip takes that technology one step further by adding a three-dimensional cavity along the channel – think of a narrow tunnel that suddenly opens into a domed vault – which creates a mini-vortex where particles spin around, making them easier to observe.
To make this cavity, researchers inserted a liquid metal drop onto the silicon mould when making the chip.
The liquid metal’s high surface tension means it holds its form during the moulding process.
Finally the liquid metal is removed, leaving just the channel and a spherical cavity ready to use as a mini-centrifuge, explained RMIT engineer and study co-leader Dr Khashayar Khoshmanesh.
“When the fluid sample enters the spherical-shaped cavity, it spins inside the cavity,” he said.
“This spinning creates a natural vortex, which just like a centrifuge machine in an analytics lab, spins the cells or other biological samples, allowing them to be studied without the need for capturing or labelling them.”
The device only requires tiny samples, as little as 1 ml of water or blood, and can be used to study tiny bacterial cells measuring just 1 micron, all the way up to human cells as large as 15 microns.
A platform for studying cardiovascular diseases
Study co-leader and RMIT Postdoctoral Research Fellow, Dr Sara Baratchi, said the device’s soft spherical cavities could be used to mimic 3D human organs and observe how cells behave in various flow conditions or drug interactions.
“The ability to tailor the size of the cavity also allows for different flow situations to be simulated – this way we can mimic the response of blood cells under disturbed flow situations, for example at branch points and curvatures of coronary and carotid arteries, which are more prone to narrowing,” she said.
This capability will be of interest to Australia’s booming biomedical industry, with medical apparatus being among our top 10 exports in 2018 and worth $3.2 billion.
Baratchi said the discovery was only made possible through collaboration, with technologists from the School of Engineering and mechano-biologists in the School of Health and Biomedical Sciences joining forces in RMIT’s Mechanobiology and Microfluidics research group.
“Biologists like myself have been struggling to study the impact of flow-associated forces on circulatory blood cells. Now this miniaturised device developed with our engineering colleagues does exactly that,” Baratchi said.
“It’s an ingenious solution that really highlights the value of cross-disciplinary research.”
But some of the most exciting applications could also be outside the lab.
A cheap and portable water test that anyone can use
Another promising application is for identifying parasites and other infections in waterways, especially in developing countries.
“Detection of water impurities can be a difficult task because you don’t always know exactly what you’re looking for,” Khoshmanesh said.
“But with this device the impurities will be captured and orbited by the vortex without any special sample preparation, saving time and money.”
Whether used for analysing water or blood samples, the low cost and portability of the device makes it attractive for a whole range of applications.
The same research group recently developed a pressure pump, made from latex balloons, to operate the device.
Unlike conventional pumps, which can be as large as a shoebox and cost thousands of dollars, theirs is low cost and portable.
“Simplicity is a very important parameter for our designs because that often translates to lower cost and great applicability outside the lab,” Khoshmanesh said.
“Our new microfluidic device, combined with our pump and a smartphone capable of capturing high-speed images, makes a low-cost, self-sufficient and entirely portable point-of-care diagnostics device.”
The Latest on: Point-of-care diagnostics device
via Google News
The Latest on: Point-of-care diagnostics device
- Semcasting’s Digital Point of Care Solution Named One of the Most Innovative Products of 2019 by PM360on December 13, 2019 at 7:00 am
NORTH ANDOVER, Mass., Dec. 13, 2019 (GLOBE NEWSWIRE) -- PM360, a leading trade magazine for marketing decision-makers in the pharmaceutical, biotech, medical device and diagnostics industries, has ...
- Take A Strategic Approach To Marketing And Communications In Pre-Revenue Environmentson December 12, 2019 at 5:03 am
This is a role I know well, as I currently manage the internal and external communications strategy of a pre-revenue startup developing a microfluidic, point-of-care diagnostic device. Pre-revenue ...
- Point Of Care Diagnostics Global Market Is Expected To Grow With A CAGR Of 3.3% In Forecast Period 2018-2026on December 12, 2019 at 12:01 am
The global point of care diagnostics/testing market was esteemed at USD 18.09 billion out of 2018 and is relied upon to enroll a CAGR of 3.3% over the figure time frame. Constant improvements in R&D ...
- Point Of Care (POC) Diagnostics Market Share, Size 2017-2025 | Top Leading Countries, Companies,on December 9, 2019 at 5:28 am
diagnostics market is anticipated to reach USD 34.6 billion by 2025.Point of Care (PoC) diagnostics, are medical devices or tools that helps to diagnose the disease in patient's community, usually ...
- A cartridge based Point-of-Care device for complete blood counton December 9, 2019 at 2:12 am
Presently, diagnostics based on blood tests are confined to centralized laboratory ... Theranos 2. While companies working in the point-of-care medical devices have raised considerable amounts of ...
- US FDA clears MolecuLight's i:X handheld fluorescence imaging device for wound managementon December 7, 2019 at 1:26 am
This clinical trial demonstrated a three-fold increase in both sensitivity and diagnostic odds ratio in the number ... when the final datafiles are distributed by the AMA. Point-of-care bacterial ...
- Takeda and Enzyre to Develop Diagnostic Device Allowing Hemophilia Patients to Determine their Coagulation Status at Homeon December 5, 2019 at 5:29 pm
About Enzyre Enzyre, based in Nijmegen, is a spin out from Radboud University Medical Center in The Netherlands aiming to develop a point-of-care diagnostic device focused on blood coagulation which ...
- Anti-Theranos: FDA Approval In Hand, Sight Diagnostics Aims At $2.7 Billion Blood Testing Giant, Sysmexon December 5, 2019 at 7:07 am
Rivals include bioMerieux, Haemonetics, Bio-Techne, Autobio Diagnostics, Guardant Health ... “If the Trust wants to adopt OLO, then it will be evaluated by our Point of Care Testing (POCT) Committee, ...
- Unlike Theranos, startup’s blood test device ‘delivers on promise’ with FDA nodon December 4, 2019 at 6:49 pm
Israeli startup Sight Diagnostics has received US Food and Drug Administration clearance to market a blood test device that can extract the results of a standard complete ... as large laboratory ...
- OPTOLANE chooses Trustonic for medical device securityon December 3, 2019 at 4:06 pm
to bring security and trust to the company’s new connected medical diagnostic device. The product is primarily used at the point-of-care for early diagnosis and preventative healthcare, particularly ...
via Bing News